Medical devices, healthcare technology and the business of care
510(k) clearance · K260600

Neuroguard IEP Embolic Protection System

Contego Medical, Inc. · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONK260600

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 11/04/2026 for the Neuroguard IEP Embolic Protection System, submitted by Contego Medical, Inc. of Raleigh, North Carolina, under 510(k) number K260600. The application was received 02/24/2026 and reviewed by the Cardiovascular panel under regulation 870.1250, product code NTE, classified as a temporary carotid catheter for embolic capture. A SESE decision is a 510(k) clearance, not a premarket approval.

The record lists two clinical trials, NCT04201132 and NCT05845710, and states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The public page does not describe the specific device components, modifications, or performance data supporting the decision, and no summary or statement is included here. Whether the listed trials informed this clearance, and what they evaluated, remains unstated in the available record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260600
Regulatory pathway
510(k) premarket notification
Product code
NTE
Decision code
SESE
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Temporary Carotid Catheter For Embolic Capture.

Product code
NTE
FDA device class
2

FDA decision timeline

  1. K260600 received

    Application receipt date recorded by FDA.

  2. K260600 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Contego Medical, Inc.

Headquarters
Not reported
Brand website
contegomedical.com
FDA applicant address
Raleigh, NC

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records